Cancer Institute– A national cancer institute
designated cancer center

Sean Mackey, M.D., Ph.D.

Back to Profile

Publication Details

  • Subcutaneous injection of botulinum toxin a is beneficial in postherpetic neuralgia.

    Xiao L, Mackey S, Hui H, Xong D, Zhang Q, Zhang D. Pain Med. 2010; 11 (12): 1827-33

    To assess the benefits of subcutaneous injection of botulinum toxin A (BTX-A) for the treatment of postherpetic neuralgia (PHN).

    PubMedID: 21134121

Stanford Medicine Resources:

Footer Links: